Skip to main content

Table 1 Descriptive statistics of population of men included in the study, stratified according to their MetS profile

From: Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study

Patients

(n = 379)

With MetS

(n = 140)

Without MetS

(n = 239)

 

Mean ± SD

Mean ± SD

p value

Demographic

Age (years)

70.0 ± 7.4

68.5 ± 8.8

0.059

BMI (Kg/m2)

27.5 ± 3.5

25.8 ± 2.4

0.000

Smokers, Number, (%)

108 (77.1%)

171 (71.5%)

0.417

Prostate

Features

Prostate Volume (cc)

88.9 ± 59.1

77.8 ± 41.2

0.053

PSA (ng/mL)

3.9 ± 3.7

3.0 ± 3.2

0.062

Prostate treatment

α-blockers, Number, (%)

103 (73.5%)

164 (68.6%)

0.200

5-ARI, Number, (%)

23 (16.4%)

33 (13.8%)

0.467

MetS parameters

WC

104.6 ± 12.9

97.2 ± 7.3

0.000

Systolic BP

134.9 ± 14.7

131.3 ± 14.6

0.016

Diastolic BP

78.7 ± 8.5

76.7 ± 8.0

0.020

Glycemia

108.8 ± 37.1

94.1 ± 16.3

0.000

Triglyceride

149.8 ± 54.3

111.2 ± 42.7

0.000

HDL Cholesterol

41.5 ± 11.0

49.1 ± 7.4

0.000